Aurinia Pharmaceuticals (AUPH) Current Leases (2020 - 2026)

Aurinia Pharmaceuticals (AUPH) has 7 years of Current Leases data on file, last reported at $1.6 million in Q1 2026.

• Quarterly Current Leases fell 88.82% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 88.82% YoY) and the FY2025 annual result came in at $16.5 million, up 1510.43% from the prior year.
• Current Leases slipped to $1.6 million in Q1 2026, from $16.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $16.5 million in Q4 2025 to a low of $918000.0 in Q3 2022.
• A 5-year average of $5.4 million and a median of $1.0 million in 2024 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases sank 92.98% — and 2025, when it jumped 1510.43%.
• Tracing AUPH's Current Leases over 5 years: stood at $918000.0 in 2022, then jumped by 1491.39% to $14.6 million in 2023, then sank by 92.98% to $1.0 million in 2024, then jumped by 1510.43% to $16.5 million in 2025, then sank by 90.18% to $1.6 million in 2026.
• The last three Current Leases figures came in at $1.6 million (Q1 2026), $16.5 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.